1 Introduction Biochemical recurrence (BCR) following definitive prostate cancer treatment with radical prostatectomy presents a significant clinical challenge, requiring accurate localization of sites of disease to inform appropriate management strategies. Current guidelines recommend the use of advanced imaging techniques such as multiparametric MRI and PSMA-targeted PET to aid with this task [1-3].
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile
Get in touch with Basil
Contact Basil, search articles and posts on X, monitor coverage, and track replies from one place.
Learn more about Muck Rack